Heart Transplant Surgery for International Patients in India

Advanced Heart Failure

Transplant is considered when severe heart failure remains refractory to guideline-directed medicines, resynchronization/defibrillator therapy, revascularization, valve intervention or other appropriate treatment. Heart failure means the heart can no longer pump enough blood for the body's needs. Many people live well with it for years on medicines and devices. Only a minority progress to the advanced stage where those treatments are no longer enough, and it is these patients who are assessed for transplant or a pump such as an LVAD.

Conditions That Can Lead to Transplant

• Dilated/nonischemic cardiomyopathy.
• Ischemic cardiomyopathy after extensive coronary disease or myocardial infarction.
• Advanced genetic/familial cardiomyopathy.
• Selected congenital heart disease.
• Restrictive or hypertrophic cardiomyopathy with end-stage physiology.
• Selected severe valvular disease when conventional surgery is no longer appropriate.
• Refractory life-threatening ventricular arrhythmias in selected structural heart disease.

Clinical Warning Signs of Advanced Disease for International Patients in India

• Repeated admissions despite optimal therapy.
• Low-output symptoms, hypotension or progressive end-organ dysfunction.
• Dependence on intravenous inotropes.
• Severe exercise limitation or recurrent congestion.
• Refractory ventricular arrhythmias.
• Progressive intolerance of heart-failure medicines because of low blood pressure or kidney dysfunction.

Referral Should Not Be Too Late

Transplant assessment is best initiated before irreversible kidney, liver, pulmonary-vascular or nutritional deterioration develops. A patient can be 'too well' today yet still benefit from early advanced-heart-failure review.

Why Do International Patients Consider India for Heart Transplant?

Patients look at India for practical reasons, but heart transplantation differs from other procedures, and the reasons need to be balanced against the legal and waiting-list realities explained in this guide:

• Cost. Private transplant episodes in India are commonly a fraction of private prices in the USA, UK and Australia, though a foreign family's full budget is wider than the headline package.
• Programme experience. Several large hospitals run heart-transplant, LVAD and ECMO programmes, and volume is closely linked to safer outcomes.
• Integrated services. Advanced heart-failure care, cardiac surgery, intensive care, infectious-disease and rehabilitation services can sit within one hospital.
• Access to a transplant pathway. Some patients from countries with limited transplant services consider India, though allocation to foreign recipients is restricted as explained above.
• Specialist review before travel. Records can be reviewed remotely, so the team can say whether transplant assessment is reasonable before a family commits.
• Language. English is widely used in Indian hospitals, and interpreters can usually be arranged.

India is a sensible option only when the patient is clinically suitable, the legal and allocation pathway is clearly explained in writing, the family can finance an uncertain wait, and a reliable follow-up plan exists at home. It is not a good option for a patient who is unstable and needs to remain with the team who already knows them, or for anyone offered a guaranteed donor heart.

How Does India Compare with Other Medical Travel Destinations?

Patients sometimes compare India with Singapore, Turkey or the Gulf. For heart transplant, the honest comparison is about legal access and the whole pathway, not the price list:

What Causes the Heart Failure That Leads to Transplant?

Heart failure is not a single disease. The conditions below can each lead to end-stage heart failure, and for some patients no cause is found:

What Are the Symptoms That Lead to Evaluation?

These symptoms are common to many conditions, but in a person with known heart disease they should prompt specialist review rather than waiting. Early referral to an advanced heart-failure service gives more options than a late referral during a crisis.

What Makes a Good Candidate?

• Advanced irreversible cardiac disease with substantial expected benefit from transplantation.
• Acceptable kidney, liver, lung and neurological status or a feasible combined-organ strategy in rare selected cases.
• No uncontrolled infection or active untreated malignancy.
• Ability to adhere to complex lifelong medicines and follow-up.
• Adequate psychosocial support and rehabilitation potential.

Contraindications Are Often Relative, Not Simply a Checklist

Age, obesity, diabetes, renal dysfunction, pulmonary hypertension, prior cancer, frailty and peripheral vascular disease require individualized assessment. Some problems can be optimized; others may make transplantation unsafe.

Pulmonary Vascular Resistance

Severe fixed pulmonary hypertension can cause acute donor right-heart failure after transplantation. Right-heart catheterization and vasodilator testing are therefore central in selected candidates.

Infection and Malignancy

Active uncontrolled infection is generally incompatible with transplantation because immunosuppression can be catastrophic. Prior cancer requires disease-specific assessment of recurrence risk and cancer-free interval.

Substance Use and Adherence

Active harmful substance use, inability to follow medication schedules or absence of reliable follow-up may prevent listing until addressed.

Cardiac Assessment

• Echocardiography.
• Coronary angiography/CT where appropriate.
• Right-heart catheterization and hemodynamics.
• Cardiopulmonary exercise testing when feasible.
• Rhythm/device review.
• Assessment for potentially correctable coronary, valve or congenital lesions.

Other-Organ Assessment

• Kidney and liver function.
• Pulmonary function and chest imaging.
• Peripheral/cerebrovascular disease assessment where indicated.
• Nutrition and frailty.
• Dental evaluation and infection screening.
• Age-appropriate cancer screening.

Infectious-Disease Work-up

Testing commonly includes HIV, hepatitis B/C, CMV, EBV, tuberculosis and other infection screening according to risk/geography. Vaccination should be optimized before transplantation whenever possible.

Immunologic Testing

Blood group, HLA-related testing and anti-HLA antibodies/PRA help assess sensitization and compatibility risk. Prior transfusions, pregnancy, mechanical circulatory support and previous transplantation can increase sensitization.

Psychosocial and Financial Assessment

The team evaluates adherence, caregiver support, ability to remain near the centre, medicine affordability and long-term access to laboratory monitoring. For an international patient, continuity of care in the home country is especially important.

Records to Send Before Travel

• Recent echo and angiography.
• Right-heart catheterization if available.
• Hospital discharge summaries.
• Current medication and device details.
• Kidney/liver tests and blood group.
• CT/chest imaging and pulmonary tests.
• Previous cardiac surgery reports.
• Infection/cancer history.
• Passport/nationality details for preliminary legal/logistical review.

The Evaluation Pathway at a Glance

Each step can change the plan, and the decision to list is revisited while you wait. A programme that explains this sequence for your case is likely to plan carefully.

Treatment Options at a Glance

Transplant is one option among several, and the right choice depends on the cause of the failure, its severity, your other organs and your wishes. The table summarises how the main pathways compare, and your own team will tailor it:

Is Treatment in India Right for You? A Short Checklist

This checklist is not a decision, but it helps you see whether you are likely to be a good candidate for transplant assessment in India. Ask yourself:

Do Not Relocate Before Preliminary Acceptance

Send records first. The transplant team should confirm that formal evaluation is reasonable and explain the foreign-national allocation pathway before the family commits to long-term accommodation.

Caregiver Planning

A reliable adult caregiver is strongly advisable. Early after transplant the patient needs help with medicines, infection precautions, transport and emergency recognition.

Accommodation

After discharge, stay close to the transplant hospital in clean accommodation with reliable transport, food hygiene and access to emergency care. The early follow-up schedule can be intensive.

Financial Reserve

Budget for an uncertain waiting period, possible hospitalization before transplant, emergency mechanical support, extended ICU stay and several weeks of post-discharge monitoring.

Medicines

Before returning home, verify availability and brand/generic equivalence of tacrolimus/cyclosporine, mycophenolate and other required medicines in the home country.

Preparing yourself before treatment (prehab)

Prehab is not about perfection. Staying as well as possible while waiting can keep you eligible, and your team will tell you which activity and diet limits apply.

Heart Transplantation Is a Deceased-Donor Programme

A donor heart comes from a deceased donor after legally recognized organ donation and allocation. The recipient cannot bring a living donor for heart transplantation.

Registration for International Patients in India

A transplant centre first evaluates medical fitness. Eligible patients are registered through the applicable organ-allocation network and require a NOTTO identification/registry process according to current rules.

Special Position of Foreign Recipients

Current Government of India guidance states that a foreign patient can be registered for a deceased-donor organ through the treating hospital, but allocation to a foreign recipient is considered only when no Indian patient is available to take that organ in the whole country.

What This Means Practically

• A transplant date cannot be promised.
• Waiting time for a foreign patient can be prolonged and unpredictable.
• The patient may need to remain in or repeatedly return to India depending on programme policy and medical stability.
• Clinical deterioration while waiting can require hospitalization, inotropes, LVAD or other support.
• Visa, accommodation and finances must account for uncertainty.

Medical Visa for International Patients in India

Government guidance requires appropriate medical-visa compliance for foreign transplant patients. Exact documentation should be confirmed with the registered transplant hospital and Indian mission before travel.

Commercial Organ Dealing Is Illegal

Buying or selling human organs is prohibited and punishable. Families should work only through registered transplant hospitals and official allocation systems.

Questions that separate honest from misleading offers

Staying Well Enough to Receive the Donor Heart

Patients are reassessed while waiting because eligibility can change. Weight, infection status, kidney/liver function, pulmonary pressures and overall condition must remain acceptable.

Medical Bridge

Diuretics, vasodilators and guideline-directed heart-failure drugs are continued as tolerated. Some patients require continuous intravenous inotropes.

Temporary Mechanical Circulatory Support

• Intra-aortic balloon pump in selected shock settings.
• Impella or other temporary ventricular support in selected centres.
• VA-ECMO for severe cardiogenic shock when appropriate.
• Temporary surgical VAD strategies in specialized programmes.

Durable LVAD

A durable left ventricular assist device can be used as bridge-to-transplant or destination therapy. It can stabilize circulation and end-organ function, but adds device, bleeding, stroke, infection and anticoagulation risks.

LVAD vs Transplant

LVAD is not simply a cheaper substitute. Age, right-heart function, body size, anatomy, transplant eligibility, donor access and long-term goals determine the strategy.

When the Patient Deteriorates

Cardiogenic shock can change urgency and support needs. The transplant team must continually reassess whether transplantation remains feasible and whether mechanical support is appropriate. Bridge options compared

Donor-Recipient Matching

• ABO blood-group compatibility.
• Body/heart size compatibility.
• Recipient urgency and allocation rules.
• Donor heart function and medical history.
• Distance and expected ischemic time.
• Immunologic/sensitization considerations.

Donor Assessment

The retrieval team reviews donor age, cause of death, hemodynamics, echocardiography, ECG, laboratory/infectious screening and coronary assessment when appropriate.

Organ Transport

Donor hearts have limited safe ischemic time. Retrieval and recipient teams coordinate operating rooms, transport and 'green corridor' logistics when needed. Machine/perfusion preservation technologies may expand options in selected programmes but are not required for every transplant.

The Recipient Is Called In

Once an organ is provisionally accepted, the recipient undergoes urgent reassessment, blood tests and preparation. Surgery may still be cancelled if final donor assessment is unfavorable or the recipient has developed a contraindication.

Orthotopic Heart Transplantation

Most procedures are orthotopic: the diseased heart is removed and the donor heart is implanted in its normal anatomical position.

Main Surgical Steps

• General anesthesia and invasive monitoring.
• Median sternotomy.
• Cardiopulmonary bypass.
• Removal of most of the native heart while preserving required atrial/vascular structures.
• Implantation of donor heart using bicaval or other established anastomotic technique.
• Connection of pulmonary artery and aorta.
• Reperfusion, rhythm/hemodynamic stabilization and weaning from bypass.
• Hemostasis, drains and chest closure.

Bicaval vs Biatrial Technique

Modern programmes commonly favor bicaval implantation because it better preserves atrial geometry and can reduce some rhythm/tricuspid-valve problems, although technique is individualized.

Previous Cardiac Surgery

Prior sternotomy, LVAD, congenital repairs or complex anatomy can make transplant surgery longer and increase bleeding/reconstruction complexity.

Combined Transplantation

Rare patients with irreversible failure of another organ may require heart-kidney, heart-liver or heart-lung transplantation. These are highly specialized pathways with separate allocation and eligibility considerations.

Your Surgery Day, Step by Step for International Patients in India

A heart transplant is unplanned in timing, so the day begins with a call. The sequence commonly follows this pattern:

Your caregiver should know where to wait and how the team will update them. The operation takes many hours, and a long time in theatre is normal.

First 24-72 Hours

• Mechanical ventilation until stable.
• Continuous hemodynamic and rhythm monitoring.
• Inotropes/vasopressors as needed.
• Assessment of donor right/left ventricular function.
• Kidney, liver and neurological monitoring.
• Early immunosuppression and infection prophylaxis.
• Bleeding and chest-drain monitoring.

Primary Graft Dysfunction

Severe early donor-heart dysfunction is one of the most serious complications. Treatment can include intensive inotropes, pulmonary vasodilators, mechanical support or ECMO.

Rhythm and Pacing

Temporary pacing may be required early. The transplanted heart is denervated, so resting heart rate and exercise response differ from a native heart.

Mobilization and Rehabilitation

Breathing exercises, sitting, standing and walking begin as soon as medically safe. Rehabilitation addresses severe pre-transplant deconditioning.

Typical Hospital Course

An uncomplicated recipient may spend several days in ICU followed by ward recovery; total hospitalization is often roughly 2-4 weeks, but infection, rejection, kidney dysfunction, graft dysfunction or prior critical illness can prolong this substantially.

Why Rejection Happens

The immune system recognizes the donor heart as foreign. Lifelong immunosuppression reduces this response but cannot eliminate rejection risk.

Types of Rejection

Endomyocardial Biopsy

Many programmes perform scheduled right-ventricular biopsies frequently in the early months, then less often. Protocols vary and noninvasive surveillance is increasingly used in selected settings.

Other Surveillance

• Echocardiography.
• ECG and clinical examination.
• Drug trough levels.
• Donor-specific antibody testing.
• Selected gene-expression or donor-derived cell-free DNA assays where available.
• Coronary imaging for allograft vasculopathy.

Symptoms Can Be Subtle

Rejection can occur without dramatic symptoms. New fatigue, breathlessness, edema, palpitations, low blood pressure or reduced exercise tolerance require urgent transplant-team review.

Typical Maintenance Immunosuppression

A common regimen combines a calcineurin inhibitor such as tacrolimus, an antiproliferative agent such as mycophenolate, and corticosteroids initially. Exact regimens vary with rejection risk, kidney function, infection and adverse effects.

Never Miss Doses

Even brief interruption can increase rejection risk. International patients need reliable access to the same medicines or transplant-approved equivalents after returning home.

Important Drug Toxicities

• Kidney dysfunction.
• Hypertension.
• Diabetes and lipid abnormalities.
• Tremor/neurotoxicity.
• Bone loss.
• Gastrointestinal or blood-count effects.
• Increased infection and malignancy risk.

Infection Prophylaxis

Recipients commonly receive prophylaxis against CMV, Pneumocystis and selected fungal/bacterial infections according to donor/recipient risk and centre protocol.

Vaccination

Vaccines should be optimized before transplant. After transplant, inactivated vaccines are generally used according to specialist schedules; live vaccines are usually avoided under significant immunosuppression.

Food and Environmental Precautions

Safe food handling, clean water, hand hygiene and avoidance of high-risk infection exposures are especially important in the early months. Common side effects of transplant medicines, and what helps

Cardiac Allograft Vasculopathy (CAV)

CAV is a diffuse form of coronary disease unique to transplanted hearts. Because the heart is denervated, classic angina may be absent. Surveillance can use angiography, intravascular imaging or other techniques.

Kidney Disease

Pre-existing heart-failure-related renal dysfunction may improve after transplant, but calcineurin inhibitors can cause chronic nephrotoxicity. Kidney monitoring is lifelong.

Cancer Risk

Chronic immunosuppression increases risk of skin cancers, lymphoproliferative disease and other malignancies. Age-appropriate screening and sun protection are important.

Metabolic Disease

Hypertension, diabetes, obesity and dyslipidemia require aggressive management because they affect graft and patient survival.

Exercise

Structured rehabilitation is encouraged. Because of denervation, heart rate rises and falls more slowly with exercise; longer warm-up and cool-down are often recommended.

What Could Go Wrong After a Heart Transplant?

No honest programme can quote one risk figure for every patient, because risk depends on how ill you are before surgery, your kidney and lung pressures, the donor heart and your response to immunosuppression. Ask the team for its own figures for patients like you.

Urgent Warning Symptoms

• Fever or chills.
• New breathlessness, edema or marked fatigue.
• Palpitations, dizziness or fainting.
• Reduced urine output.
• Persistent vomiting/diarrhea that may alter drug absorption.
• New neurological symptoms.
• Missed immunosuppression because of supply problems.

Because the transplanted heart has no nerve supply, warning signs can be subtle. Share the table below with your companion and keep the transplant team's emergency number on your phone.

What You Can Do to Reduce Your Risk

Early Recovery Timeline for International Patients in India

The table above gives the general focus, and the table below shows what you and your companion may experience and can do at each stage. Rejection, infection, kidney function and the severity of your illness before transplant can change the timetable.

Fit to Fly

International travel is considered only after the transplant team is satisfied with graft function, wound healing, rejection status, infection risk, drug levels and ability to access care during/after travel.

Flight Preparation

• Carry all medicines in hand luggage plus extra supply.
• Carry transplant summary, donor/recipient information permitted for release, prescriptions and emergency contacts.
• Maintain strict medication timing across time zones.
• Use infection precautions in crowded airports according to transplant-team advice.
• Request wheelchair assistance if stamina is limited.
• Know where emergency/transplant care is available at the destination.

Driving and Work

Return depends on sternotomy healing, strength, medication effects and local regulations. Many patients return gradually to work after recovery, but timing is individualized.

How Long to Stay Near the Transplant Hospital

The hospital stay is often roughly 2-4 weeks when uncomplicated, followed by weeks of close outpatient monitoring. Families should plan for a long stay after the operation itself, plus the waiting period before it, and keep return dates flexible until the team confirms that it is safe to fly.

Practical Questions Patients Ask After the Operation

When can I leave the ICU and the hospital? Often after several days in the ICU and roughly 2-4 weeks in hospital when all goes well, but rejection, infection or kidney problems can extend this. Can I eat normally? Usually yes, from the first days. Food hygiene is very important, and your dietitian will advise about raw foods, grapefruit and salt. When can I start walking and exercising? Walking starts in the first days. Structured cardiac rehabilitation follows, with a longer warm-up and cool-down because the transplanted heart responds slowly. Will I feel my heart racing? The new heart has no nerve supply at first, so heart rate rises and falls slowly with exertion. Some nerve re-connection may develop over time. Can I lift or drive? Lifting is limited while the breastbone heals, often for about six to eight weeks. Driving depends on healing, strength and local rules. Will I need frequent biopsies? They are frequent in the first months and become less frequent if the graft is stable. Some programmes also use blood tests and echo to reduce the need for biopsies. Can I return to work? Many patients return gradually after recovery, with timing individualised to the job and your health. Can I have follow-up at home? Yes, if a home cardiologist or transplant centre agrees to share care and your Indian team is available for remote advice. Do I need to avoid crowds? In the early months, yes, as advised by your team. Masks and hand hygiene reduce infection risk. Can I travel again after transplant? Often yes, after you are stable and have a reliable medicine supply and care plan at your destination.

Travel Practicalities After Heart Transplant

What Must Continue at Home

• Immunosuppressant trough levels.
• Kidney/liver function and blood counts.
• Blood pressure, glucose and lipid monitoring.
• Echocardiography and rejection surveillance.
• CAV surveillance.
• Cancer screening and dermatology.
• Vaccination/infection prevention.
• Cardiac rehabilitation and exercise.

Emotional Wellbeing and Realistic Expectations

Waiting for a donor heart, the sudden call and a long recovery in a foreign country are emotionally exhausting for patients and families. Anxiety, low mood, guilt about the donor family and fear of rejection are common, and they respond to support. Tell your team if low mood, anxiety or poor sleep continues, because treatment helps. Counselling, a transplant support group and a sense of purpose through rehabilitation all matter, and your companion needs support too. Living after heart transplant at a glance

Special Situations

Children Pediatric transplantation has unique congenital anatomy, growth, sensitization and adherence considerations. Families require long-term pediatric transplant support. Older Patients Chronological age alone is not the sole determinant. Frailty, cancer risk, renal function, vascular disease and expected benefit are central. Diabetes and Obesity These may increase infection, wound and metabolic risk but are not automatically disqualifying if well controlled and within programme criteria. Kidney Dysfunction The team determines whether dysfunction is reversible with improved cardiac output or represents irreversible intrinsic kidney disease. Selected patients may need combined heart-kidney transplantation. Prior LVAD LVAD recipients can undergo transplantation, but prior device surgery may increase adhesions, bleeding and infection complexity. Highly Sensitized Patients High anti-HLA antibody burden can reduce compatible donor options and increase antibody-mediated rejection risk. Specialized desensitization/virtual-crossmatch strategies may be considered. Special situations at a glance

Questions to Ask the Programme

• Is the hospital currently registered/authorized for heart transplantation?
• How many adult/pediatric heart transplants does the programme perform?
• What are early survival and major complication rates?
• How are foreign recipients registered and prioritized under current allocation rules?
• What is the programme's experience with LVAD/ECMO bridge-to-transplant?
• Who manages rejection, infection and endomyocardial biopsies?
• What is the plan if the patient waits months without a donor?
• How will follow-up be coordinated in my home country?

Four more questions to ask

• Will the surgeon and heart-failure cardiologist who review my records be the ones who manage me, and who covers when they are away?
• Will my case be discussed by the transplant selection committee before I am listed, and can I receive its decision in writing?
• Can I speak with a previous international transplant patient, or see the cardiac ICU and ward?
• Who will manage my immunosuppression and send reports to my home doctor after I return?

Essential Hospital Capabilities

• Advanced heart-failure cardiology.
• Cardiac transplant surgery and donor-retrieval team.
• 24/7 cardiac ICU and ECMO.
• Mechanical circulatory support/LVAD programme.
• Transplant infectious disease.
• Immunology/HLA laboratory access.
• Cath lab and endomyocardial biopsy capability.
• Cardiac rehabilitation, nutrition and pharmacy.
• Dedicated transplant coordinator and international-patient team.

What a Good International Patient Service Should Provide

Red Flags

• Guaranteed donor or guaranteed transplant date.
• Payment requested to obtain a donor organ.
• No explanation of foreign-recipient allocation priority.
• No long-term immunosuppression plan.
• No LVAD/ECMO capability in a programme managing unstable candidates.
• A fixed package that ignores prolonged ICU stay or complications.

Survival and Quality of Life

Modern heart transplantation can provide many years of survival and major improvement in function for appropriately selected recipients. Outcomes depend on age, pre-transplant condition, donor factors, rejection/infection, adherence and long-term graft health.

What to Expect: A Realistic Picture

No guide can tell you your own outlook, which only your transplant team can estimate from your condition, kidney and lung status, antibodies, donor factors and adherence. In general terms:

Use these as orientation only. Ask your own team for its programme-specific results for patients like you, and be wary of any centre that quotes an unusually high success rate without stating how patients were selected.

Current India Planning Range

Major Indian hospital sources currently quote roughly INR 20-35 lakh for the core transplant episode in many standard cases. International-patient costs can be higher after adding evaluation, prolonged waiting, donor retrieval/transport, complex ICU care, complications and post-discharge monitoring.

Practical International-Patient Budget

For planning rather than quotation, a foreign family should consider a wider total episode budget than the advertised operation package—often approximately US$30,000-50,000+ for a relatively uncomplicated transplant episode, with potentially much higher expenditure if waiting, LVAD support, prolonged ICU care or complications occur.

Why a One-Price Package Is Misleading

Heart-transplant cost varies dramatically with preoperative severity, kidney function, mechanical support, donor transport, ICU duration, infection and rejection. Published Indian cost analyses have likewise shown wide patient-to-patient variation.

International Cost Comparison

*These are broad planning comparisons, not equivalent packages. Deceased-donor access and allocation rules differ substantially between countries. Savings are calculated against the India midpoint and rounded, and the Canada and Singapore rows are indicative additions. Many countries restrict or prioritise donor hearts for their own residents, so a lower price abroad does not mean a foreign patient can actually be listed there, and the price comparison matters only if a legal pathway to a donor heart exists.

What a Hospital Quote Should Clarify

• Evaluation package.
• Transplant surgery and surgeon/anesthesia fees.
• Expected ICU and ward days.
• Donor retrieval and transport charges.
• Blood products and advanced life support.
• Induction/maintenance immunosuppression during admission.
• Biopsies and early surveillance.
• Exclusions for dialysis, ECMO, reoperation, infection or prolonged ICU stay.
• Post-discharge clinic/lab/biopsy costs.
• LVAD costs if transplant is delayed.

Compare Eligibility and Access Before Price

A lower operation price is irrelevant if a foreign patient has little realistic access to a donor heart. Obtain written clarification of registration, allocation priority, expected waiting strategy and bridge options.

Budgeting for the Whole Pathway, Not Just the Operation

The hospital quote is only part of the budget. A realistic plan also includes:

• Return flights for you and a caregiver, with flexible dates and wheelchair assistance.
• Accommodation and meals near the hospital for the waiting period, if required, and for several weeks to months after transplant.
• Repeated clinic visits, tests, drug levels and biopsies while listed and after transplant.
• Lifelong immunosuppressants and other medicines, with a plan for supply at home.
• Emergency admission, LVAD or ECMO support if you deteriorate while waiting.
• Medical visa fees and travel insurance that covers complications.
• Follow-up tests and consultations at home, and possible future care for rejection or graft vasculopathy.
• A contingency for a longer wait, extra ICU days, infection or a cancelled donor call.

Quotation Comparison Table for International Patients in India

Use this table to compare written quotations from two hospitals on the same terms:

What Should the Quotation Say About Complications?

• Who pays if a complication such as rejection, infection, bleeding or kidney failure occurs during the same admission?
• What is charged if the stay is longer than planned, ICU care is extended or a second operation is needed?
• Whether ECMO, dialysis, return to theatre and readmission are covered, and for how long after surgery.
• What follow-up visits, drug levels and biopsies are included before you leave India.
• Whether remote follow-up with the team after you return home is free or charged.

Remote Case Review Before Booking for International Patients in India

• Send echo, angiography and right-heart catheterisation reports, and discharge summaries.
• List all medicines and any device, such as an ICD or LVAD, with its details.
• Include kidney, liver, blood group, antibody and infection results.
• Ask in writing how a foreign national is registered and prioritised.
• Obtain a preliminary view on whether formal evaluation is reasonable, and a cost range.

A good review says whether transplantation is likely to be the right option, whether another treatment such as valve repair, a rhythm device or an LVAD could help first, what the foreign-national pathway looks like and what must be clarified before you relocate.

Typical Pathway

The Waiting Period Cannot Be Predicted Reliably

Blood group, size, clinical urgency, donor availability, sensitization and—critically for foreigners in India—allocation priority all affect waiting.

Cancellation After a Donor Call

Occasionally the donor heart is found unsuitable at retrieval or the recipient becomes temporarily unfit. This is emotionally difficult but reflects safety, not necessarily programme failure.

Medical Visa and Attendant for International Patients in India

Confirm current Indian medical/e-Medical visa eligibility and attendant rules for your nationality. Hospitals generally provide treatment/invitation letters after medical review, and requirements can change. Most patients apply for an e-Medical Visa, and a caregiver can apply for an e-Medical Attendant Visa. Because the waiting period is uncertain, ask the hospital and the Indian mission how extensions are handled before you travel, and check fees, validity and eligible nationalities on the official Indian e-Visa website.

Documents to Carry Home

• Operative report and discharge summary.
• Immunosuppression regimen with target drug levels.
• Rejection/biopsy reports.
• Donor/recipient serology information appropriate for clinical follow-up.
• Echo/cath results.
• Infection-prophylaxis plan.
• Vaccination guidance.
• Emergency contact and scheduled review dates.

Your information pack: why each item matters

Arranging Your Follow-Up at Home Before You Leave for International Patients in India

Identify a cardiologist, ideally one with transplant experience, a laboratory able to measure tacrolimus or cyclosporine levels, a pharmacy that can reliably supply your medicines and, if possible, a transplant centre willing to share care. Send them your records before you travel, and agree how your Indian team will receive results and advise on dose changes.

Language, Consent and Communication

• Ask for the consent form and discharge instructions in a language you understand.
• Ask for an interpreter if your English is limited; do not rely on guesses for risks or medicines.
• Make sure the consent explains the transplant, the chance of rejection, infection, kidney injury and graft failure, the need for lifelong medicines and what happens if the donor heart is unsuitable.
• If the patient is a minor, make sure the parent or guardian's consent and the child's own understanding are both addressed.
• Agree who will receive updates, and how, if you cannot answer on the day, including during an urgent donor call.
• Save the hospital, transplant coordinator and surgeon contact numbers before you travel, and keep your own copies of everything you sign.

Medical Questions

• Is transplantation truly the best option now?
• Can any valve, coronary, rhythm or congenital treatment delay/avoid transplant?
• What are my pulmonary vascular resistance and end-organ risks?
• Would LVAD be a better bridge or destination option?
• Am I sensitized?
• What factors could remove me from the waiting list?

India-Specific Questions for a Foreign Patient

• Can your hospital legally register me for a deceased-donor heart?
• What is my allocation priority as a foreign national under current rules?
• Must I remain in India while waiting?
• How often must I attend the hospital while listed?
• What happens if I deteriorate before a donor becomes available?
• What is the estimated monthly waiting-period cost?
• Can you coordinate post-transplant monitoring with my home-country cardiologist?

Financial Questions

• What is included in the transplant package?
• Is donor retrieval/transport included?
• How many ICU/ward days are included?
• What is excluded if ECMO/dialysis/reoperation is needed?
• What do early biopsies and medicines cost?
• What is the monthly cost of lifelong immunosuppression?

More questions worth asking

• Who will I speak to at night or at weekends if I feel unwell while waiting?
• What happens to my fees and visa if the wait is much longer than expected?
• Will my immunosuppressants be available, and at what cost, when I return home?
• Can you share your programme's one-year survival and rejection figures for recipients like me?

Records Checklist for a Second Opinion

• Echocardiogram and angiography reports.
• Right-heart catheterisation if available.
• Discharge summaries from recent admissions.
• Medication list and device details.
• Kidney and liver tests, blood count and blood group.
• Infection and cancer history.
• Passport and nationality information.

Planning Heart Transplant in India – International Patient Checklist

Final Perspective for International Patients

Transplant care works best when the need is certain, alternatives have been considered, the pathway to a donor heart is explained honestly, and the whole journey, from waiting to lifelong follow-up, is budgeted and arranged in advance. For an international patient considering India, the review of your records, the honesty about what a foreign recipient can realistically expect, the clarity about waiting costs and complications, and the arrangement of follow-up at home are as important as the operation itself. Educational guide only. Heart-transplant candidacy, organ allocation and travel decisions require assessment by an authorized transplant programme and must follow current Indian law and allocation policy.

Sources

• Cleveland Clinic - Heart Transplant: https://my.clevelandclinic.org/health/treatments/17087-heart-transplant
• Mayo Clinic - Heart transplant process: https://mayoclinic.org/process/art-20037052
• Government of India - Indian Visa Online (e-Medical Visa and e-Medical Attendant Visa): https://indianvisaonline.gov.in/evisa/

Hero photo: “Health Health - Stethoscope” by Formulate Health, via Wikimedia Commons, licensed CC BY 2.0.